HWAIL PHARMACEUTICAL Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following businesses: Pharmaceutical Raw Material, Cephalosporin Antibiotic, Functional Health Food Ingredient. Its products include antitussive expectorants, spasmolytic, stomach function modifier, anti-inflammatory and others. The company was founded on November 18, 1980 and is headquartered in Hwaseong, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company